Adverse-drug-reaction related admissions to a hospital in Scotland
- 346 Downloads
Aims To apply established methods to identify ADR-related admissions and to determine the proportion which was preventable and which were caused by non-prescription medicines (NPMs). Methods This prospective, observational study screened all acute hospital admissions (n = 1,101) by ward pharmacists over a 2-week period. Suspected ADR-related admissions were reported to the researcher and established criteria were used to evaluate probability, causality and preventability of the ADR-related admissions. Results Of the 1,101 emergency admissions which occurred during the study period, 30 were categorised as ADR-related, equating to a prevalence of 2.7% (95% CI, 1.8–3.7%). Three (9.7%) of the 30 admissions were associated with NPMs. The ADR was the dominant reason for admission in 56.7% (n = 17/30) and only 13.3% (n = 4/30) of all reported admissions were assessed as unavoidable. Conclusion The proportion of ADR-related admissions was lower than in previous studies in the UK. A substantial proportion of ADRs was associated with NPMs, highlighting the need for greater awareness amongst patients, prescribers and other health care professionals regarding possible serious adverse effects caused by these medicines.
KeywordsAdverse drug reaction Hospital admission Non-prescription drug OTC medicines Prescription medicines Scotland
We thank the ward pharmacists at Aberdeen Royal Infirmary for screening the admissions as well as Shona Fielding and John Townend for their statistical support.
Yvonne Hopf was supported by the Clinical Pharmacology Programme Scholarship at University of Aberdeen.
Conflicts of interest
- 1.WHO. Safety of medicines – a guide to detecting and reporting adverse drug reactions. 2002.Google Scholar
- 13.Rawlins MD, Thomas SHL. Mechanisms of adverse drug reactions. In: Davies DM, Ferner RE, de Glanville H, editors. Davies’s textbook of adverse drug reactions. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1998. ISBN 0412824809.Google Scholar
- 16.Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharm J. 2003;270:583–6.Google Scholar
- 19.Committee on Safety of Medicines. Annual report (2002), NHS Scotland Edinburgh.Google Scholar
- 20.Teweleit S, Kuschel U, Hippius M, Goettler M, Bornschein B. Manifestation and possible prevention of adverse drug reactions (ADR) in pharmacotherapy of cardiovascular diseases. Med Klin. 2001;96(8):442–50. Manifestation and Praeventationsmoeglichkeiten unerwuenschter Arzneimittelwirkungen (UAW) in der Pharmakotherapie von Herz-Kreislauf-Erkrankungen. doi: 10.1007/PL00002226.Google Scholar